Okyo Pharma Limited (OKYO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2010 | 03-2009 | 03-2008 | |
| Operating Expenses | -20,595 | -15,097 | 3,165 |
| Operating Income | 20,595 | 15,097 | -3,165 |
| Other Income | -7,923 | -762 | 190 |
| Pre-tax Income | 12,673 | 14,335 | -2,975 |
| Net Income Continuous | 12,673 | 14,335 | -2,975 |
| Net Income | $12,673 | $14,335 | $-2,975 |
| EPS Basic Total Ops | 0.03 | 0.03 | -0.03 |
| EPS Basic Continuous Ops | 0.03 | 0.03 | -0.03 |
| EPS Diluted Total Ops | 0.02 | 0.03 | -0.03 |
| EPS Diluted Continuous Ops | 0.02 | 0.03 | -0.03 |
| EBITDA(a) | $20,595 | $15,097 | $-3,165 |